Clinical studies recruiting near West Monroe

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Phase 3 · SWOG Cancer Research Network · NCT05929768 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Merck Sharp & Dohme LLC · NCT06393374 Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Th
Phase 3 · Amgen · NCT07225686 A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · FIN-10090, West Monroe, LA · Colorado Prevention Center · NCT06033950 Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Phase N/A · Wake Forest University Health Sciences · NCT06418204 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carbop
Phase 3 · Boehringer Ingelheim · NCT07472517 A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are Hi
Phase 3 · Merck Sharp & Dohme LLC · NCT06667700 EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes,
Phase 3 · Monroe Research, LLC · Boehringer Ingelheim · NCT07064473 Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Perc
Phase 4 · Monroe Research LLC · Duke University · NCT06909565 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433 Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressur
Phase 3 · Amgen · NCT07226765 Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Phase 3 · Vertex Pharmaceuticals Incorporated · NCT07231419 A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Ou
Phase 3 · Delta Research Partners of West Monroe · Eli Lilly and Company · NCT07165028 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Alliance for Clinical Trials in Oncology · NCT05677490 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · NRG Oncology · NCT06748222 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Canadian Cancer Trials Group · NCT06592924 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-10090, West Monroe, LA · Colorado Prevention Center · NCT06024746 A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Phase 3 · Delta Research Partners of West Monroe, LLC · Ardelyx · NCT07382167 Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After
Phase 3 · Alliance for Clinical Trials in Oncology · NCT05812807 Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small
Phase 2/Phase 3 · National Cancer Institute (NCI) · NCT04402788 Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Phase 3 · National Cancer Institute (NCI) · NCT06337318 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · NRG Oncology · NCT05624996 Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal
Phase 3 · NRG Oncology · NCT05879926 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · ECOG-ACRIN Cancer Research Group · NCT04566328 Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Phase 2/Phase 3 · Monroe Research, LLC · Vertex Pharmaceuticals Incorporated · NCT05312879 A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic
Phase 2 · Delta Research Partners of West Monroe, LLC · Rivus Pharmaceuticals, Inc. · NCT07491458 Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab
Phase 2 · NRG Oncology · NCT05327686 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · NRG Oncology · NCT05174169 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · National Cancer Institute (NCI) · NCT04267848 Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Phase 3 · SWOG Cancer Research Network · NCT06807437

Look up another city

Look up another condition